advertisement
John D 19
Showing records 1 to 19 | Display all abstracts from John D108690 Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance data
Shanmugasundaram D
Heliyon 2023; 9: e15965
108074 Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine Program: First-Year Outcomes and Implementation Costs
Newman-Casey PA; Niziol LM
American Journal of Ophthalmology 2023; 251: 43-51
108690 Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance data
Verma S
Heliyon 2023; 9: e15965
108074 Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine Program: First-Year Outcomes and Implementation Costs
Elam AR
American Journal of Ophthalmology 2023; 251: 43-51
108690 Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance data
Singh K; Dwibedi B
Heliyon 2023; 9: e15965
108074 Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine Program: First-Year Outcomes and Implementation Costs
Bicket AK
American Journal of Ophthalmology 2023; 251: 43-51
108690 Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance data
Awasthi S
Heliyon 2023; 9: e15965
108074 Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine Program: First-Year Outcomes and Implementation Costs
Killeen O
American Journal of Ophthalmology 2023; 251: 43-51
108690 Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance data
Mahantesh S
Heliyon 2023; 9: e15965
108074 Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine Program: First-Year Outcomes and Implementation Costs
John D; Wood SD
American Journal of Ophthalmology 2023; 251: 43-51
108690 Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance data
Singh H
Heliyon 2023; 9: e15965
108074 Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine Program: First-Year Outcomes and Implementation Costs
Musch DC
American Journal of Ophthalmology 2023; 251: 43-51
108690 Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance data
Santhanam S; Mondal N
Heliyon 2023; 9: e15965
108074 Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine Program: First-Year Outcomes and Implementation Costs
Zhang J; Johnson L
American Journal of Ophthalmology 2023; 251: 43-51
108690 Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance data
S G; Sreenivasan P
Heliyon 2023; 9: e15965
108074 Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine Program: First-Year Outcomes and Implementation Costs
Kershaw M
American Journal of Ophthalmology 2023; 251: 43-51
108690 Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance data
Malik S
Heliyon 2023; 9: e15965
108074 Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine Program: First-Year Outcomes and Implementation Costs
Woodward MA
American Journal of Ophthalmology 2023; 251: 43-51
108690 Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance data
Jain M; Viswanathan R; Tripathi S; Patel B; Sapkal G; Sabarinathan R; Singh MP; Ratho RK; Nag V; Gadepalli R; Som TK; Mishra B; Jain A; Ashok M; Madhuri DS; Rani VS; Abraham AM; John D; Dhodapkar R; Syed Ali A; Biswas D; Pratyeke D; Bavdekar A; Prakash J; Singh V; Prasad N; Ray J; Majumdar A; Majumdar A; Dutta S; Gupta N; Murhekar M; ; Sharma A; Ghosh A; Alexander A; Baranwal A; Anantharaj A; Bethou A; Shekhawat DS; Kiruthika G; Ram J; Gupta M; Gowda M; Rohit MK; Dash N; Sankhyan N; Kaushal N; Shivanna NH; Kasturi N; Kumar PP; Gupta PC; Gunasekaran PK; Singh P; Kumar P; Munjal SK; Agarwal S; Manasa S; Shukla S; Nehra U; Verghese VP; Vyas V; Gupta V
Heliyon 2023; 9: e15965
